Company profile SLNO
After 38 days of this quarter the interest is at 45.0. Based on that we can calculate that during remaining 53 days it will total up to 108.0. Soleno Therapeutics expected interest is significantly higher compared to same quarter last year (+71.4%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 73 | 60 -17.8% QoQ | 29 -51.7% QoQ | 29 0.0% QoQ |
| 2020 | 52 -28.8% YoY 79.3% QoQ | 135 125.0% YoY 159.6% QoQ | 43 48.3% YoY -68.1% QoQ | 38 31.0% YoY -11.6% QoQ |
| 2021 | 99 90.4% YoY 160.5% QoQ | 64 -52.6% YoY -35.4% QoQ | 88 104.7% YoY 37.5% QoQ | 58 52.6% YoY -34.1% QoQ |
| 2022 | 23 -76.8% YoY -60.3% QoQ | 26 -59.4% YoY 13.0% QoQ | 37 -58.0% YoY 42.3% QoQ | 31 -46.6% YoY -16.2% QoQ |
| 2023 | 63 173.9% YoY 103.2% QoQ | 64 146.2% YoY 1.6% QoQ | 144 289.2% YoY 125.0% QoQ | 123 296.8% YoY -14.6% QoQ |
| 2024 | 45 -28.6% YoY -63.4% QoQ | - | - | - |
The average 5 years interest of Soleno Therapeutics was 5.07 per week. The last year interest of Soleno Therapeutics compared to the last 5 years has changed by 62.33%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 94.56%.
After 38 days of this quarter the interest is at 40.0. Based on that we can calculate that during remaining 53 days it will total up to 96.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 30 | 73 143.3% QoQ | 37 -49.3% QoQ | 66 78.4% QoQ |
| 2020 | 87 190.0% YoY 31.8% QoQ | 262 258.9% YoY 201.1% QoQ | 30 -18.9% YoY -88.5% QoQ | 88 33.3% YoY 193.3% QoQ |
| 2021 | 145 66.7% YoY 64.8% QoQ | 63 -76.0% YoY -56.6% QoQ | 58 93.3% YoY -7.9% QoQ | 45 -48.9% YoY -22.4% QoQ |
| 2022 | 80 -44.8% YoY 77.8% QoQ | 55 -12.7% YoY -31.2% QoQ | 29 -50.0% YoY -47.3% QoQ | 28 -37.8% YoY -3.4% QoQ |
| 2023 | 126 57.5% YoY 350.0% QoQ | 129 134.5% YoY 2.4% QoQ | 159 448.3% YoY 23.3% QoQ | 124 342.9% YoY -22.0% QoQ |
| 2024 | 40 -68.3% YoY -67.7% QoQ | - | - | - |
The average 5 years interest of Soleno Therapeutics stock was 6.72 per week. The last year interest of Soleno Therapeutics stock compared to the last 5 years has changed by 46.28%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 148.23%.
After 38 days of this quarter the interest is at 116.0. Based on that we can calculate that during remaining 53 days it will total up to 278.0. Soleno Therapeutics news expected interest is significantly higher compared to previous quarter (+286.1%) and same quarter last year (+1444.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 11 | 49 345.5% QoQ | 0 -100.0% QoQ | 39 inf% QoQ |
| 2020 | 41 272.7% YoY 5.1% QoQ | 74 51.0% YoY 80.5% QoQ | 39 inf% YoY -47.3% QoQ | 40 2.6% YoY 2.6% QoQ |
| 2021 | 30 -26.8% YoY -25.0% QoQ | 78 5.4% YoY 160.0% QoQ | 32 -17.9% YoY -59.0% QoQ | 14 -65.0% YoY -56.2% QoQ |
| 2022 | 18 -40.0% YoY 28.6% QoQ | 39 -50.0% YoY 116.7% QoQ | 49 53.1% YoY 25.6% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 18 0.0% YoY inf% QoQ | 19 -51.3% YoY 5.6% QoQ | 29 -40.8% YoY 52.6% QoQ | 72 inf% YoY 148.3% QoQ |
| 2024 | 116 544.4% YoY 61.1% QoQ | - | - | - |
The average 5 years interest of Soleno Therapeutics news was 3.09 per week. The last year interest of Soleno Therapeutics news compared to the last 5 years has changed by 57.93%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 111.26%.
There is not enough data for Soleno Therapeutics website to provide analysis
There is not enough data for Soleno Therapeutics website to provide correlation calculation
There is not enough data for Soleno Therapeutics website to provide analysis
There is not enough data for Soleno Therapeutics treatment to provide analysis
There is not enough data for Soleno Therapeutics treatment to provide correlation calculation
There is not enough data for Soleno Therapeutics treatment to provide analysis
There is not enough data for Soleno Therapeutics rare diseases to provide analysis
There is not enough data for Soleno Therapeutics rare diseases to provide correlation calculation
There is not enough data for Soleno Therapeutics rare diseases to provide analysis
There is not enough data for Diazoxide Choline Extended-Release tablets to provide analysis
There is not enough data for Diazoxide Choline Extended-Release tablets to provide correlation calculation
There is not enough data for Diazoxide Choline Extended-Release tablets to provide analysis
After 38 days of this quarter the interest is at 151.0. Based on that we can calculate that during remaining 53 days it will total up to 362.0. Prader-Willi Syndrome expected interest is significantly lower compared to previous quarter (-47.0%) and same quarter last year (-55.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 367 | 303 -17.4% QoQ | 415 37.0% QoQ | 374 -9.9% QoQ |
| 2020 | 392 6.8% YoY 4.8% QoQ | 450 48.5% YoY 14.8% QoQ | 469 13.0% YoY 4.2% QoQ | 387 3.5% YoY -17.5% QoQ |
| 2021 | 493 25.8% YoY 27.4% QoQ | 450 0.0% YoY -8.7% QoQ | 480 2.3% YoY 6.7% QoQ | 403 4.1% YoY -16.0% QoQ |
| 2022 | 644 30.6% YoY 59.8% QoQ | 662 47.1% YoY 2.8% QoQ | 508 5.8% YoY -23.3% QoQ | 603 49.6% YoY 18.7% QoQ |
| 2023 | 804 24.8% YoY 33.3% QoQ | 624 -5.7% YoY -22.4% QoQ | 538 5.9% YoY -13.8% QoQ | 683 13.3% YoY 27.0% QoQ |
| 2024 | 151 -81.2% YoY -77.9% QoQ | - | - | - |
The average 5 years interest of Prader-Willi Syndrome was 39.08 per week. The last year interest of Prader-Willi Syndrome compared to the last 5 years has changed by 20.01%. The interest for Prader-Willi Syndrome is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 52.62%.
There is not enough data for Soleno Therapeutics clinical trials to provide analysis
There is not enough data for Soleno Therapeutics clinical trials to provide correlation calculation
There is not enough data for Soleno Therapeutics clinical trials to provide analysis
There is not enough data for Soleno Therapeutics biography to provide analysis
There is not enough data for Soleno Therapeutics biography to provide correlation calculation
There is not enough data for Soleno Therapeutics biography to provide analysis